BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37986913)

  • 1. Boston criteria v2.0 for cerebral amyloid angiopathy without hemorrhage: An MRI-neuropathological validation study.
    Switzer A; Charidimou A; McCarter SJ; Vemuri P; Nguyen A; Przybelski SA; Lesnick TG; Rabinstein AA; Brown RD; Knopman DS; Petersen RC; Jack CR; Reichard RR; Graff-Radford J
    medRxiv; 2023 Nov; ():. PubMed ID: 37986913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Boston Criteria v2.0 for Cerebral Amyloid Angiopathy Without Hemorrhage: An MRI-Neuropathologic Validation Study.
    Switzer AR; Charidimou A; McCarter S; Vemuri P; Nguyen AT; Przybelski SA; Lesnick TG; Rabinstein AA; Brown RD; Knopman DS; Petersen RC; Jack CR; Reichard RR; Graff-Radford J
    Neurology; 2024 May; 102(10):e209386. PubMed ID: 38710005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study.
    Charidimou A; Boulouis G; Frosch MP; Baron JC; Pasi M; Albucher JF; Banerjee G; Barbato C; Bonneville F; Brandner S; Calviere L; Caparros F; Casolla B; Cordonnier C; Delisle MB; Deramecourt V; Dichgans M; Gokcal E; Herms J; Hernandez-Guillamon M; Jäger HR; Jaunmuktane Z; Linn J; Martinez-Ramirez S; Martínez-Sáez E; Mawrin C; Montaner J; Moulin S; Olivot JM; Piazza F; Puy L; Raposo N; Rodrigues MA; Roeber S; Romero JR; Samarasekera N; Schneider JA; Schreiber S; Schreiber F; Schwall C; Smith C; Szalardy L; Varlet P; Viguier A; Wardlaw JM; Warren A; Wollenweber FA; Zedde M; van Buchem MA; Gurol ME; Viswanathan A; Al-Shahi Salman R; Smith EE; Werring DJ; Greenberg SM
    Lancet Neurol; 2022 Aug; 21(8):714-725. PubMed ID: 35841910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Boston Criteria v2.0/v1.5 for Cerebral Amyloid Angiopathy to Predict Recurrent Intracerebral Hemorrhage.
    Fandler-Höfler S; Gattringer T; Enzinger C; Werring DJ
    Stroke; 2023 Jul; 54(7):1901-1905. PubMed ID: 37264913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity and Specificity of the Boston Criteria Version 2.0 for the Diagnosis of Cerebral Amyloid Angiopathy in a Community-Based Sample.
    Zanon Zotin MC; Makkinejad N; Schneider JA; Arfanakis K; Charidimou A; Greenberg SM; van Veluw SJ
    Neurology; 2024 Jan; 102(1):e207940. PubMed ID: 38165367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI and CT imaging biomarkers of cerebral amyloid angiopathy in lobar intracerebral hemorrhage.
    Schwarz G; Banerjee G; Hostettler IC; Ambler G; Seiffge DJ; Ozkan H; Browning S; Simister R; Wilson D; Cohen H; Yousry T; Al-Shahi Salman R; Lip GYH; Brown MM; Muir KW; Houlden H; Jäger R; Werring DJ
    Int J Stroke; 2023 Jan; 18(1):85-94. PubMed ID: 34994246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Diagnosis of Probable Cerebral Amyloid Angiopathy: Diagnostic Accuracy Meta-Analysis of the Boston Criteria.
    Charidimou A; Boulouis G
    Stroke; 2022 Dec; 53(12):3679-3687. PubMed ID: 36065807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advancing diagnostic criteria for sporadic cerebral amyloid angiopathy: Study protocol for a multicenter MRI-pathology validation of Boston criteria v2.0.
    Charidimou A; Frosch MP; Al-Shahi Salman R; Baron JC; Cordonnier C; Hernandez-Guillamon M; Linn J; Raposo N; Rodrigues M; Romero JR; Schneider JA; Schreiber S; Smith EE; van Buchem MA; Viswanathan A; Wollenweber FA; Werring DJ; Greenberg SM;
    Int J Stroke; 2019 Dec; 14(9):956-971. PubMed ID: 31514686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simplified Edinburgh CT Criteria for Identification of Lobar Intracerebral Hemorrhage Associated With Cerebral Amyloid Angiopathy.
    Sembill JA; Knott M; Xu M; Roeder SS; Hagen M; Sprügel MI; Mrochen A; Borutta M; Hoelter P; Engelhorn T; Rothhammer V; Macha K; Kuramatsu JB
    Neurology; 2022 May; 98(20):e1997-e2004. PubMed ID: 35314501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity of the Boston criteria version 2.0 in Dutch-type hereditary cerebral amyloid angiopathy.
    van der Zwet R; Koemans EA; Voigt S; van Dort R; Rasing I; Kaushik K; van Harten TW; Schipper MR; Terwindt GM; van Osch M; van Walderveen M; van Etten ES; Wermer M
    Int J Stroke; 2024 Mar; ():17474930241239801. PubMed ID: 38444323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simplified Edinburgh and modified Boston criteria in relation to amyloid PET for lobar intracerebral hemorrhage.
    Michiels L; Dobbels L; Demeestere J; Demaerel P; Van Laere K; Lemmens R
    Neuroimage Clin; 2022; 35():103107. PubMed ID: 35853346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applicability of the Edinburgh CT Criteria for Lobar Intracerebral Hemorrhage Associated with Cerebral Amyloid Angiopathy.
    Grangeon L; Roussel M; Gillibert A; Verdalle-Cazes M; Dolores M; Ozkul-Wermester O; Gilard V; Derrey S; Maltête D; Gerardin E; Joly LM; Wallon D; Magne N
    Clin Neuroradiol; 2023 Jun; 33(2):455-465. PubMed ID: 36598532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral amyloid angiopathy - The modified Boston criteria in clinical practice.
    Caetano A; Ladeira F; Barbosa R; Calado S; Viana-Baptista M
    J Neurol Sci; 2018 Jan; 384():55-57. PubMed ID: 29249378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. White matter perivascular spaces: an MRI marker in pathology-proven cerebral amyloid angiopathy?
    Charidimou A; Jaunmuktane Z; Baron JC; Burnell M; Varlet P; Peeters A; Xuereb J; Jäger R; Brandner S; Werring DJ
    Neurology; 2014 Jan; 82(1):57-62. PubMed ID: 24285616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of Intracerebral Hemorrhage and Mortality After Convexity Subarachnoid Hemorrhage in Cerebral Amyloid Angiopathy.
    Calviere L; Viguier A; Patsoura S; Rousseau V; Albucher JF; Planton M; Pariente J; Cognard C; Olivot JM; Bonneville F; Raposo N
    Stroke; 2019 Sep; 50(9):2562-2564. PubMed ID: 31337297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-hemorrhagic imaging markers of cerebral amyloid angiopathy in memory clinic patients.
    Costa AS; Albrecht M; Reich A; Nikoubashman O; Schulz JB; Reetz K; Pinho J
    Alzheimers Dement; 2024 Jun; ():. PubMed ID: 38865440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of lobar microbleeds in individuals without intracerebral hemorrhage.
    Martinez-Ramirez S; Romero JR; Shoamanesh A; McKee AC; Van Etten E; Pontes-Neto O; Macklin EA; Ayres A; Auriel E; Himali JJ; Beiser AS; DeCarli C; Stein TD; Alvarez VE; Frosch MP; Rosand J; Greenberg SM; Gurol ME; Seshadri S; Viswanathan A
    Alzheimers Dement; 2015 Dec; 11(12):1480-1488. PubMed ID: 26079413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral amyloid angiopathy-related acute lobar intra-cerebral hemorrhage: diagnostic value of plain CT.
    Baron JC; Boulouis G; Benzakoun J; Schwall C; Oppenheim C; Turc G; Varlet P
    J Neurol; 2022 Apr; 269(4):2126-2132. PubMed ID: 34510255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors for Late Post-Intracerebral Hemorrhage Dementia in Patients with Probable Cerebral Amyloid Angiopathy.
    Xiong L; Charidimou A; Pasi M; Boulouis G; Pongpitakmetha T; Schirmer MD; Singh S; Benson E; Gurol EM; Rosand J; Greenberg SM; Biffi A; Viswanathan A
    J Alzheimers Dis; 2019; 71(2):435-442. PubMed ID: 31403947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral amyloid angiopathy: Neuropathological diagnosis, link to Alzheimer's disease and impact on clinics.
    Thal DR; Gawor K
    Clin Neuropathol; 2023; 42(5):176-189. PubMed ID: 37489069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.